De-implementation of Outdated Colonoscopy Surveillance Interval Recommendations Among Patients With Low-risk Adenomas
NCT ID: NCT05389397
Last Updated: 2023-09-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
604 participants
INTERVENTIONAL
2022-05-12
2023-09-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
NCT05080673
Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study
NCT05994482
Improving the Frequency of Colonoscopy in Patients With a Previous Colorectal Polyp
NCT00397969
Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps
NCT06376565
Efficacy of Second Forward-view Examination of Left Colon for Adenoma Detection During Colonoscopy
NCT05651893
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mailed Letter
Outreach
Mailed letter, secure message or telephone outreach will be used depending on arm enrolled
Secure Message
Outreach
Mailed letter, secure message or telephone outreach will be used depending on arm enrolled
Telephone Outreach
Outreach
Mailed letter, secure message or telephone outreach will be used depending on arm enrolled
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Outreach
Mailed letter, secure message or telephone outreach will be used depending on arm enrolled
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Primary medical center is either KP San Rafael, KP San Francisco, KP San Leandro, or KP Walnut Creek
* 54-70 years of age at time of 5-year surveillance colonoscopy interval
* A baseline colonoscopy with a finding of 1-2 small tubular adenomas and are due for their 5-year surveillance procedure in 2022
* Average risk for CRC
* A valid mailing address, kp.org account (i.e., KPNC's secure messaging portal), and telephone number at time of study enrollment.
Exclusion Criteria
54 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kaiser Permanente
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeffrey K Lee, MD
Role: STUDY_CHAIR
Kaiser Permanente
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kaiser Permanente San Francisco Medical Center
San Francisco, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lee JK, Koripella PC, Jensen CD, Merchant SA, Fox JM, Chang SX, Dang CH, Velayos FS, Boparai ES, Evans NS, Leung LJ, Badalov JM, Quesenberry CP, Corley DA, Levin TR. Randomized Trial of Patient Outreach Approaches to De-implement Outdated Colonoscopy Surveillance Intervals. Clin Gastroenterol Hepatol. 2024 Jun;22(6):1315-1322.e7. doi: 10.1016/j.cgh.2023.12.027. Epub 2024 Jan 6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1789503-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.